Unknown

Dataset Information

0

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.


ABSTRACT: Circulating tumor cells (CTCs), an advantageous target of liquid biopsy, is an important biomarker for the prognosis and monitoring of cancer. Currently, detection techniques for CTCs are mainly based on the physical and/or epithelial characteristics of tumor cells. However, biofunctional activity markers that can indicate the high metastatic capacity of CTCs are lacking.Functional microarray, quantitative real-time polymerase chain reaction, and Western blot were used on five prostate cancer cell lines with different metastatic capacities to identify the metastasis-related metabolic genes. The identified genes were detected in the CTCs of 64 clinical samples using the RNA in situ hybridization. A multi-criteria weighted model was used to determine the optimal metabolic markers for the CTCs test. Based on five fluorescent signals targeting DAPI, CD45, metabolic, epithelial (EpCAM/CKs), and mesenchymal (Vimentin/Twist) markers, the filtration-enriched CTCs were classified as GM+CTCs/GM-CTCs (metabolic types) or E-CTCs/H-CTCs/M-CTCs (EMT types). Correlation analysis and ROC curve were conducted on 54 prostate cancer samples to evaluate the clinical significance of CTCs subtypes.Eight metastasis-related metabolic genes were identified, including HK2, PDP2, G6PD, PGK1, PHKA1, PYGL, PDK1, and PKM2. Among them, PGK1 and G6PD were determined as optimal glucose metabolic (GM) markers for CTCs. GM+CTCs (marked by PGK1/G6PD) were detectable in 64.8% (35/54) of prostate cancer patients, accounting for 46.5% (134/288) of total CTCs. An increased GM+CTCs level was associated with advanced tumor stage and metastasis (P?

SUBMITTER: Chen J 

PROVIDER: S-EPMC6025832 | biostudies-other | 2018 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.

Chen Jing J   Cao Shunwang S   Situ Bo B   Zhong Juan J   Hu Yanwei Y   Li Shufen S   Huang Jinlan J   Xu Jiasen J   Wu Shiyang S   Lin Jinduan J   Zhao Qianwen Q   Cai Zhen Z   Zheng Lei L   Wang Qian Q  

Journal of experimental & clinical cancer research : CR 20180628 1


<h4>Background</h4>Circulating tumor cells (CTCs), an advantageous target of liquid biopsy, is an important biomarker for the prognosis and monitoring of cancer. Currently, detection techniques for CTCs are mainly based on the physical and/or epithelial characteristics of tumor cells. However, biofunctional activity markers that can indicate the high metastatic capacity of CTCs are lacking.<h4>Methods</h4>Functional microarray, quantitative real-time polymerase chain reaction, and Western blot w  ...[more]

Similar Datasets

| S-EPMC10166919 | biostudies-literature
| S-EPMC3338784 | biostudies-literature
| S-EPMC3743247 | biostudies-literature
| S-EPMC4990782 | biostudies-literature
| S-EPMC3141292 | biostudies-literature
| S-EPMC7408664 | biostudies-literature
| S-EPMC3885705 | biostudies-literature
| S-EPMC5529747 | biostudies-other
| S-EPMC6830444 | biostudies-literature
| S-EPMC5663539 | biostudies-literature